Home › Cancro metastatico › Arizona › Tucson
Studi clinici su Cancro metastatico a Tucson, AZ
14 studi su Cancro metastatico cercano partecipanti presso sedi a Tucson e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
In reclutamentoFase 1
- University of Arizona Cancer Center, Tucson
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
In reclutamentoFase 2/3
- The University of Arizona Cancer Center, Tucson
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
In reclutamentoFase 2
- The University of Arizona Cancer Center - North Campus, Tucson
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
In reclutamentoFase 3
- The University of Arizona Cancer Center - North Campus, Tucson
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
In reclutamentoFase 3
- The University of Arizona Cancer Center - North Campus, Tucson
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
In reclutamentoFase 3
- The University of Arizona Cancer Center - North Campus, Tucson
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
In reclutamentoFase 3
- University of Arizona-Cancer Center, Tucson
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
In reclutamentoFase 1
- University of Arizona - Cancer Center, Tucson
FOG-001 in Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Arizona Cancer Center at University of Arizona, Tucson
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
In reclutamentoFase 3
- Research Site, Tucson
Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers
In reclutamento
- University of Arizona Cancer Center, Tucson
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
In reclutamentoFase 3
- The University of Arizona Cancer Center, Tucson
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
In reclutamentoFase 1
- The University of Arizona Cancer Center, Tucson
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
In reclutamentoFase 1
- University of Arizona, Tucson
Studi su Cancro metastatico in altre città
- Houston, TX104 studi
- New York City, NY93 studi
- Nashville, TN70 studi
- Boston, MA63 studi
- Los Angeles, CA57 studi
- St. Louis, MO54 studi
- Arlington, VA53 studi
- Philadelphia, PA46 studi
- Chicago, IL45 studi
- San Antonio, TX44 studi
- Washington, DC43 studi
- Dallas, TX42 studi
Altri studi a Tucson
- Cancro al seno20 studi
- Obesità18 studi
- Cancro del polmone non a piccole cellule17 studi
- Sovrappeso15 studi
- Cancro (tutti i tipi)12 studi
- Malattie cardiovascolari12 studi
- Cancro colorettale11 studi
- Cancro alla prostata11 studi
- Diabete di tipo 211 studi
- Malattia epatica steatosica10 studi
- Insufficienza cardiaca10 studi
- Pressione alta10 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.